
Phaarmasia Hits Upper Circuit Amidst Unprecedented Buying Interest
2025-12-05 09:50:26Phaarmasia Ltd has surged to a new 52-week high of Rs.79.9, locking in an upper circuit with only buy orders in the queue, signalling extraordinary demand and a potential multi-day circuit scenario. The stock’s performance today outpaces the broader Sensex and its sector, reflecting sustained investor enthusiasm in the Pharmaceuticals & Biotechnology space.
Read More
Phaarmasia Hits New 52-Week High of Rs.76.1, Marking Strong Momentum
2025-12-04 09:58:42Phaarmasia, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.76.1 today, reflecting a sustained rally and robust market momentum over the past several weeks.
Read More
Phaarmasia Surges to Upper Circuit Amid Unprecedented Buying Interest
2025-12-04 09:35:38Phaarmasia Ltd has witnessed extraordinary buying momentum, hitting the upper circuit with only buy orders in the queue. The stock’s uninterrupted rally and absence of sellers suggest a potential multi-day circuit scenario, underscoring robust investor enthusiasm in the Pharmaceuticals & Biotechnology sector.
Read More
Phaarmasia Hits New 52-Week High of Rs.72.48 Marking Strong Momentum
2025-12-03 09:56:29Phaarmasia, a key player in the Pharmaceuticals & Biotechnology sector, reached a fresh 52-week high of Rs.72.48 today, reflecting a sustained upward trajectory over the past fortnight. This milestone underscores the stock's robust momentum amid a mixed market environment.
Read More
Phaarmasia Surges to Upper Circuit with Unprecedented Buying Interest
2025-12-03 09:30:28Phaarmasia Ltd has captured market attention by hitting its upper circuit limit today, with an extraordinary buying momentum and no sellers in the queue. The stock opened at its new 52-week high of ₹72.48 and has maintained this price throughout the trading session, signalling a potential multi-day circuit scenario driven by sustained demand in the Pharmaceuticals & Biotechnology sector.
Read More
Phaarmasia Hits New 52-Week High of Rs.69.03, Marking Strong Momentum
2025-12-02 09:56:35Phaarmasia, a key player in the Pharmaceuticals & Biotechnology sector, reached a fresh 52-week high of Rs.69.03 today, reflecting a sustained rally that has captured market attention. The stock’s performance over the past fortnight underscores a notable momentum in an otherwise cautious market environment.
Read More
Phaarmasia Surges to Upper Circuit with Unprecedented Buying Interest
2025-12-02 09:35:37Phaarmasia Ltd has witnessed extraordinary buying momentum, hitting its upper circuit limit today with no sellers in the queue. The pharmaceutical and biotechnology stock has recorded a remarkable 4.99% gain intraday, opening and trading at its new 52-week high of ₹69.03, signalling a potential multi-day circuit scenario driven by sustained demand and investor enthusiasm.
Read More
Phaarmasia Hits New 52-Week High of Rs.65.75 Marking Strong Momentum
2025-12-01 11:14:18Phaarmasia, a key player in the Pharmaceuticals & Biotechnology sector, reached a fresh 52-week high of Rs.65.75 today, reflecting sustained momentum and notable gains over the past several weeks. This milestone underscores the stock’s robust performance relative to its sector and broader market indices.
Read More
Phaarmasia Surges to Upper Circuit with Unprecedented Buying Interest
2025-12-01 09:30:30Phaarmasia Ltd has captured market attention by hitting the upper circuit limit today, with an extraordinary influx of buy orders and no sellers in the queue. This rare scenario underscores a powerful buying momentum that could extend over multiple trading sessions, reflecting robust investor confidence in the pharmaceuticals and biotechnology sector.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
15-Nov-2025 | Source : BSENewspaper Publication of the Unaudited Financial Results for the Quarter and Half Year Ended 30th September 2025.
Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025
14-Nov-2025 | Source : BSESubmission of Unaudited Financial Results for the Quarter and Half Year Ended 30th September 2025
Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025
14-Nov-2025 | Source : BSESubmission of Unaudited Financial results for the Quarter and Half Year Ended 30th September 2025
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






